Views of patients with inflammatory bowel disease on the COVID-19 pandemic and the health care service - a Quality study

Patients with chronic diseases have experienced substantial changes to the routine management of their conditions during the coronavirus disease 2019 (COVID-19). Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract. Patients with IBD frequently require treatment with immunosuppressant medications, which can increase the risk of infection. The purpose of this quality study is to investigate the patients’ experience of the health care service, including the effect of visit restrictions made from Mars 12th and their concerns related to their disease and SARS- CoV-2, their psychological health, as well as their health care service needs in follow-up and treatment during the Covid-19 pandemic. This valuable information will guide how we facilitate healthcare service for IBD patients and develop guidelines for follow-up if there is a "new wave" of covid-19 and possibly new pandemics. A questionnaire is administered to the patients attending the Day Care Unit at the Division of Medicine, Oslo University Hospital, Ullevål.

Project leader:

Randi Opheim

Page visits: 7679